Baker McKenzie has advised Main Capital Partners on the deal. Main Capital Partners has acquired a majority stake in IQ Messenger, a prominent provider of vendor-neutral...
Main Capital Partners Acquires Majority Stake in IQ Messenger
Minoryx Therapeutics and Neuraxpharm Group’s Development of a New CNS Therapy in Europe
Baker McKenzie advised Minoryx Therapeutics on the deal. Clifford Chance advised the Neuraxpharm Group. Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments...
Galapagos’ Acquisition of CellPoint
Wilson Sonsini Goodrich & Rosati advised CellPoint on the deal. Walder Wyss has advised +ND Capital, while Baker McKenzie advised CellPoint and AboundBio. Galapagos, a fully...
H.I.G. Capital’s Acquisition of Aspire Pharma
Baker McKenzie advised H.I.G. Capital on the transaction. H.I.G. Capital, a leading global alternative investment firm with $45 billion of equity capital under management, announced that...